Spine phila pa 1976.
Stem cell therapy for degenerative disc disease uk.
A 2003 meta analysis of animal studies.
Stem cell therapy for degenerative disc disease in particular uses mesenchymal stem cells taken from adipose and bone marrow tissue.
Mesenchymal stem cells mscs isolated from bone marrow bm mscs and adipose tissue ad mscs show considerable promise for lower back disc regeneration.
The purpose of the study is to identify genes that could serve as a target for early intervention and treatment for degenerative disk disease.
It is an alternative to surgical removal of the disc or fusion surgery.
Beginning at middle age our disc degeneration begins with the discs losing fluid flattening and becoming more brittle.
Autologous stem cell therapy maintains vertebral blood flow and contrast diffusion through the endplate in experimental intervertebral disc degeneration.
All patients must have a physical exam by a medical professional as well as a recent mri of the lumbar spine.
Stem cell transplant viable stem cell therapy has demonstrated potential to be a disease modifying or disease reversing therapy for degenerative disc disease.
Once harvested from a patient these stem cells are carefully counted and prepared into an aspirate that is then reinjected into the affected area of the same patient i e an autologous treatment.
Any other ancillary studies will also be considered.
Intervertebral disks from the cervical and lumbar spine have been retrieved from surgery and evaluated.
Biologic stem cell therapy injections into the disc may calm the inflammation reduce pain and may help repair the flattened brittle or protruding disc.
It harnesses natural repair cells removed from your body fat to target problems affecting discs joints tendons ligaments and muscles.
Translational studies addressing technology for stem cell delivery are also important.